Lunai Bioworks

LNAI
0.16480.00% ( 0.0000 )
Delay Closed: Nov 6, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -0.21, below the reasonable range, cheaper than 89.27% of the time in the past 1 years, and the industry ranks 109/606, the industry Median -1.79.

-0.21xP/E
Stock price--

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-53.60x161.61%$207.00B
MRNAUSModerna
-36.39x16.99%$101.48B
CSLLYUSCSL Limited
-25.82x--$66.59B
NTRAUSNatera
-271.87x5.68%$44.78B
RVMDUSRevolution Medicines
-22.03x43.93%$41.21B
ROIVUSRoivant Sciences
-105.48x146.69%$28.08B
INSMUSInsmed
-41.44x74.21%$25.10B
BNTXUSBioNTech SE
-12.99x21.80%$21.98B
BBIOUSBridgebio Pharma
-24.44x31.08%$14.47B
SMMTUSSummit Therapeutics
-15.64x19.30%$13.03B
KYMRUSKymera Therapeutics
-31.35x8.45%$10.95B
BMRNUSBioMarin Pharma
-567.71x60.62%$10.85B
PCVXUSVaxcyte
-8.76x50.42%$10.06B
MDGLUSMadrigal Pharma
-59.39x86.94%$9.23B
SYREUSSpyre Therapeutics
-40.88x56.38%$9.16B
IBRXUSImmunityBio
-9.22x151.32%$9.15B
ARWRUSArrowHead Pharma
-25.68x35,923.70%$8.22B
TWSTUSTwist Bioscience
-58.16x28.63%$7.95B
PRAXUSPraxis Precision Medicines
-22.86x3.71%$7.75B
RYTMUSRhythm Pharma
-38.99x34.73%$7.73B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.